Good effort and I am reminded of similar efforts done by ihub members for CTIX for their 1st in class antibiotic Brilacidin.
The members had a lot of confidence in the drug but even after a lot of advertise and contacts, nothing much happened as the phase 3 trial has still not started even after 2 years.
So in the end - it is trial progress and success which people believe.
Let's get the next trial for A2-73 get started and it will carry much more weight and get visibility.